Some studies show that diet can affect neurological conditions. Do you think the ketogenic diet can reduce symptoms in adults with epilepsy? Take our poll to voice your opinion.
Some studies show that diet can affect neurological conditions. Do you think the ketogenic diet can reduce symptoms in adults with epilepsy? Take our poll to voice your opinion.
Members of the Pediatric Epilepsy Research Consortium recently completed a survey about their prescribing practices of home seizure rescue medications for acute prolonged seizures and clusters of seizures in children. Read more to find out...
Members of the Pediatric Epilepsy Research Consortium recently completed a survey about their prescribing practices of home seizure rescue medications for acute prolonged seizures and clusters of seizures in children. Read more to find out...
Researchers analyzed whether children aged younger than 3 years who have intractable epilepsy can benefit from a ketogenic diet. And if so, do certain children benefit more than others?
Researchers analyzed whether children aged younger than 3 years who have intractable epilepsy can benefit from a ketogenic diet. And if so, do certain children benefit more than others?
Do you think immune modulatory therapy is a viable option for individuals with refractory adult-onset epilepsy who also develop psychiatric or cognitive impairment? Let us know by taking our poll.
Do you think immune modulatory therapy is a viable option for individuals with refractory adult-onset epilepsy who also develop psychiatric or cognitive impairment? Let us know by taking our poll.
More than 3 million individuals in the United States have epilepsy. Do you think it is appropriate to change the dose of a patient’s antiepileptic drug before starting or switching to a new drug? Take our poll to let us know.
More than 3 million individuals in the United States have epilepsy. Do you think it is appropriate to change the dose of a patient’s antiepileptic drug before starting or switching to a new drug? Take our poll to let us know.
Children with autism are more likely to have epilepsy, and vice versa. Madeline Fields, MD, from Mount Sinai Hospital, answers our questions about this connection.
Children with autism are more likely to have epilepsy, and vice versa. Madeline Fields, MD, from Mount Sinai Hospital, answers our questions about this connection.
Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.
Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.
Researchers have identified several risk factors for SUDEP. However, the majority of SUDEP cases appear to be linked to epilepsy-related cardio-respiratory autonomic dysfunction.
Researchers have identified several risk factors for SUDEP. However, the majority of SUDEP cases appear to be linked to epilepsy-related cardio-respiratory autonomic dysfunction.
Treatment outcome prediction models for patients with newly diagnosed epilepsy have a universally high risk of bias, researchers reported in a systematic review of nearly 50 such models published in the journal Epilepsia.
Treatment outcome prediction models for patients with newly diagnosed epilepsy have a universally high risk of bias, researchers reported in a systematic review of nearly 50 such models published in the journal Epilepsia.
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
No association was found between exposure to antiseizure medications (ASMs), including valproate, during pregnancy and children developing epilepsy, in a recent prospective, population-based register cohort study results published in JAMA...
No association was found between exposure to antiseizure medications (ASMs), including valproate, during pregnancy and children developing epilepsy, in a recent prospective, population-based register cohort study results published in JAMA...
The risk of epilepsy in post-9/11 US veterans with moderate or severe traumatic brain injury (TBI) is higher in those who were not deployed compared with those who were deployed, according to study findings published online ahead of print...
The risk of epilepsy in post-9/11 US veterans with moderate or severe traumatic brain injury (TBI) is higher in those who were not deployed compared with those who were deployed, according to study findings published online ahead of print...
The cerebellum contributes to generalized convulsive seizures by altering the activity of a specific group of neurons in the midbrain that subsequently initiates the seizures, new study results suggest.
The cerebellum contributes to generalized convulsive seizures by altering the activity of a specific group of neurons in the midbrain that subsequently initiates the seizures, new study results suggest.
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Although the ketogenic diet, modified Atkins diet, and low glycemic index therapy were each more effective than care as usual for short-term seizure reduction in childhood drug-resistant epilepsy, the modified Atkins diet may be the most...
Although the ketogenic diet, modified Atkins diet, and low glycemic index therapy were each more effective than care as usual for short-term seizure reduction in childhood drug-resistant epilepsy, the modified Atkins diet may be the most...
Combining a modified Atkins diet with medication reduced seizures and improved quality of life in adolescents and adults with drug-resistant epilepsy, according to findings from a randomized controlled trial published in Neurology.
Combining a modified Atkins diet with medication reduced seizures and improved quality of life in adolescents and adults with drug-resistant epilepsy, according to findings from a randomized controlled trial published in Neurology.
The bidirectional association between depression and epilepsy is a long-term relationship, according to a large-scale cohort study published in the journal Neurology.
The bidirectional association between depression and epilepsy is a long-term relationship, according to a large-scale cohort study published in the journal Neurology.
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke.
“In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke.
“In aging...
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
To view accreditation information/faculty disclosures for the program, click
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
To view accreditation information/faculty disclosures for the program, click
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
To view accreditation information/faculty disclosures for the program, click
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
To view accreditation information/faculty disclosures for the program, click